Graft Polymer (UK) PLC Total Voting Rights
01 August 2024 - 2:00AM
RNS Regulatory News
RNS Number : 1938Y
Graft Polymer (UK) PLC
31 July 2024
31
July 2024
Graft Polymer (UK)
plc
("Graft Polymer" or
the "Company")
Total Voting
Rights
Graft Polymer (UK) plc (LON:GPL),
announces that the Company's issued share capital as at the date of
this announcement comprises 2,295,930,633 Ordinary Shares with one
voting right each. The Company does not hold any Ordinary Shares in
treasury. Therefore, the total number of Ordinary Shares and voting
rights in the Company is 2,295,930,633.
The above figure may be used by
shareholders in the Company as the denominator for the calculations
by which they will determine if they are required to notify their
interest in, or a change to their interest in, the share capital of
the Company.
Enquiries:
Graft Polymer (UK) Plc
Anthony Tennyson, CEO and Executive Director
Email: anthonytennyson@graftpolymer.co.uk
Yifat Steuer, CFO and Executive Director
Email: yifat@graftpolymer.co.uk
Allenby Capital (Broker)
Nick Naylor
/ Liz Kirchner (Corporate Finance) | Guy McDougall
(Sales)
+44 (0) 20 3328 5656
About Graft Polymer (UK) Plc
Graft Polymer plc ("Graft Polymer")
(LSE:GPL) is an innovative biopolymer drug delivery systems
development company dedicated to enabling biopharmaceutical
companies to enhance the effectiveness of their therapeutics. Our
proprietary platform, a bioabsorbable self-nanoemulsifying drug
delivery system (SNEDDS), represents a cutting-edge solution in
drug delivery technology. By integrating active pharmaceutical
ingredients (APIs) into our novel, patented delivery systems, we
enable clients to improve the pharmacokinetics, bioavailability,
and stability of their therapeutics.
For more information, please visit
www.graftpolymer.co.uk.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact
rns@lseg.com or visit
www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our
Privacy
Policy.
END
TVRFZGZNRLLGDZG
Graft Polymer (uk) (LSE:GPL)
Historical Stock Chart
From Nov 2024 to Dec 2024
Graft Polymer (uk) (LSE:GPL)
Historical Stock Chart
From Dec 2023 to Dec 2024
